enVVeno Medical Corporation (NVNO) Q2 2024 Earnings
NVNO·Reported July 31, 2024·Before market open
Diluted EPS came in at $-0.31, beat the $-0.36 consensus by $0.05.
Diluted EPS
$-0.31beat by $0.05
Consensus: $-0.36
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about enVVeno Medical Corporation's Q2 2024 earnings report.
enVVeno Medical Corporation (NVNO) reported Q2 2024 earnings on July 31, 2024 before market open.
enVVeno Medical Corporation reported diluted EPS of $-0.31 for Q2 2024.
EPS beat the consensus estimate of $-0.36 by $0.05.
You can read the 10-Q periodic report (0001493152-24-029737) directly on SEC EDGAR. The filing index links above go to sec.gov.